Trial NCT02833506

View at ClinicalTrials.gov 
Org. Study IDs: I 277115
Secondary IDs: I 277115 NCI-2016-00811 P30CA016056 R01CA158318

Last trial update was posted on 2018-05-01

MeSH Interventions

Sirolimus

MeSH Conditions

Carcinoma Carcinoma, Ovarian Epithelial Fallopian Tube Neoplasms Ovarian Neoplasms Peritoneal Neoplasms Recurrence

Other Conditions

Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer

Stopping Reasons

production of adjuvant to be used with vaccine was discontinued by sponsor

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID